Jinxin Fertility Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Jinxin Fertility Group şirketinin toplam hissedar öz sermayesi CN¥10.3B ve toplam borcu CN¥2.1B olup, bu da borç-öz sermaye oranını 20.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥14.8B ve CN¥4.6B dir. Jinxin Fertility Group 'in FAVÖK'ü CN¥472.3M faiz karşılama oranı 8.5 dur. Şirketin CN¥772.3M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

20.9%

Borç/özkaynak oranı

CN¥2.14b

Borç

Faiz karşılama oranı	8.5x
Nakit	CN¥772.26m
Eşitlik	CN¥10.27b
Toplam yükümlülükler	CN¥4.58b
Toplam varlıklar	CN¥14.85b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 1951 'nin kısa vadeli varlıkları ( CN¥1.3B ) kısa vadeli yükümlülüklerini ( CN¥2.2B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: 1951 'un kısa vadeli varlıkları ( CN¥1.3B ) uzun vadeli yükümlülüklerini ( CN¥2.3B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 1951 'nin net borç/öz sermaye oranı ( 13.4% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 1951 şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 20.9% seviyesine yükseldi.

Borç Kapsamı: 1951 'nin borcu işletme nakit akışı ( 34.1% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 1951 'in borcuna ilişkin faiz ödemeleri EBIT ( 8.5 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Jinxin Fertility Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Investor sentiment deteriorates as stock falls 25%

Investor sentiment improves as stock rises 18%

First half 2024 earnings released: EPS: CN¥0.071 (vs CN¥0.084 in 1H 2023)

Jinxin Fertility Group Limited to Report First Half, 2024 Results on Aug 29, 2024

Investor sentiment deteriorates as stock falls 18%

Upcoming dividend of HK$0.059 per share

Investor sentiment improves as stock rises 15%

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Jinxin Fertility Group Limited, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 25 July 2024

Jinxin Fertility Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

Investor sentiment improves as stock rises 15%

Non-Executive Director recently bought HK$2.0m worth of stock

Co-CEO & Executive Director recently bought HK$3.6m worth of stock

Investor sentiment deteriorates as stock falls 17%

Jinxin Fertility Group Limited Announces Change of Chief Financial Officer

First half 2023 earnings released: EPS: CN¥0.084 (vs CN¥0.076 in 1H 2022)

Jinxin Fertility Group Limited to Report First Half, 2023 Results on Aug 29, 2023

Co-CEO & Executive Director recently bought HK$7.8m worth of stock

Full year 2022 earnings released: EPS: CN¥0.049 (vs CN¥0.14 in FY 2021)

Investor sentiment deteriorates as stock falls 18%

Now 23% undervalued

Jinxin Fertility Group Limited has completed a Follow-on Equity Offering in the amount of HKD 1.176875 billion.

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Chairman of the Board recently bought HK$6.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First half 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.063 in 1H 2021)

Jinxin Fertility Group Limited to Report First Half, 2022 Results on Aug 31, 2022

Jinxin Fertility Group Limited Declares Final Dividend for the Year Ended December 31, 2021

Investor sentiment improved over the past week

Upcoming dividend of HK$0.074 per share

Investor sentiment improved over the past week

Jinxin Fertility Group Limited, Annual General Meeting, Jun 28, 2022

CO-CEO & Executive Director recently bought HK$15m worth of stock

Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020)

Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended December 31, 2021, Payable on July 22, 2022

Investor sentiment deteriorated over the past week

CEO & Executive Director recently bought HK$1.9m worth of stock

CEO & Executive Director recently bought HK$1.0m worth of stock

First half 2021 earnings released: EPS CN¥0.063 (vs CN¥0.048 in 1H 2020)

Independent Non-Executive Director Haw Kuang Lim has left the company

Joint Company Secretary Suet Wing Leung has left the company

CEO & Executive Director recently bought HK$6.2m worth of stock

Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019)

Chairman of the Board Bin Wang has left the company

Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019)

Jinxin Fertility Group Limited to Report Q4, 2020 Results on Mar 28, 2021

New 90-day high: HK$19.40

New 90-day high: HK$17.22

New 90-day high: HK$15.80

New 90-day high: HK$15.04

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: HK$11.80

New 90-day low: HK$9.65

First half earnings released

New 90-day low: HK$9.76

First half earnings released

Jinxin Fertility Group Limited to Report First Half, 2020 Results on Aug 31, 2020

Jinxin Fertility Group Limited Announces Management Changes

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin